Rodella, Margie .

HRN: 21-20-77  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/15/2026
02/22/2026
IV
4.5g
Q6h
T/C Hepatitis Encephalopathy
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: